Literature DB >> 4359301

Phosphorylation of vesicular stomatitis virus in vivo and in vitro.

S A Moyer, D F Summers.   

Abstract

The structural protein, NS, of purified vesicular stomatitis virus (VSV) is a phosphoprotein. In infected cells phosphorylated NS is found both free in the cytoplasm and as part of the viral ribonucleoprotein (RNP) complex containing both the 42S RNA and the structural proteins L, N, and NS, indicating that phosphorylation occurs as an early event in viral maturation. VSV contains an endogenous protein kinase activity, probably of host region, which catalyzes the in vitro phosphorylation of the viral proteins NS, M, and L, but not of N or G. The phosphorylated sites on NS appear to be different in the in vivo and in vitro reactions, and are differentially sensitive to alkaline phosphatase. After removal of the membrane components of purified VSV with a dextran-polyethylene glycol two-phase separation, the kinase activity remains tightly associated with the viral RNP. However, viral RNP isolated from infected cells shows only a small amount of kinase activity. The protein kinase enzyme appears to be a cellular contaminant of purified VSV because an activity from the uninfected cell extract can phosphorylate in vitro the dissociated viral proteins NS and M. The virion-associated activity may be derived either from the cytoplasm or the plasma membrane of the host cell since both of these cellular components contain protein kinase activity similar to that found in purified VSV.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4359301      PMCID: PMC355316     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  36 in total

1.  Cyclic adenosine 3',5'-monophosphate-dependent protein kinase of human erythrocyte membranes.

Authors:  C S Rubin; J Erlichman; O M Rosen
Journal:  J Biol Chem       Date:  1972-10-10       Impact factor: 5.157

2.  Classification of rhabdovirus proteins: a proposal.

Authors:  R R Wagner; L Prevec; F Brown; D F Summers; F Sokol; R MacLeod
Journal:  J Virol       Date:  1972-12       Impact factor: 5.103

3.  Cytoplasmic compartmentalization of the protein and ribonucleic acid species of vesicular stomatitis virus.

Authors:  R R Wagner; M P Kiley; R M Snyder; C A Schnaitman
Journal:  J Virol       Date:  1972-04       Impact factor: 5.103

4.  Proteins of vesicular stomatitis virus. 3. Intracellular synthesis and extracellular appearance of virus-specific proteins.

Authors:  C Y Kang; L Prevec
Journal:  Virology       Date:  1971-12       Impact factor: 3.616

5.  Protein kinase associated with RNA tumor viruses and other budding RNA viruses.

Authors:  M Hatanaka; E Twiddy; R V Gilden
Journal:  Virology       Date:  1972-02       Impact factor: 3.616

6.  Protein kinase and phosphate acceptor proteins in Rauscher murine leukaemia virus.

Authors:  M Strand; J T August
Journal:  Nat New Biol       Date:  1971-09-29

7.  Nucleoside triphosphate phosphotransferase. A new enzyme activity of oncogenic and non-oncogenic "budding" viruses.

Authors:  P Roy; D H Bishop
Journal:  Biochim Biophys Acta       Date:  1971-04-14

8.  Phosphorylated polypeptides in adenovirus-infected cells.

Authors:  W C Russell; J J Shekel; R Machado; H G Pereira
Journal:  Virology       Date:  1972-12       Impact factor: 3.616

9.  Viron-associated protein kinase and its involvement in nongenetic reactivation of frog polyhedral cytoplasmic deoxyribovirus.

Authors:  M Gravell; T L Cromeans
Journal:  Virology       Date:  1972-06       Impact factor: 3.616

10.  Protein kinase activity in equine herpesvirus.

Authors:  C C Randall; H W Rogers; D N Downer; G A Gentry
Journal:  J Virol       Date:  1972-02       Impact factor: 5.103

View more
  22 in total

1.  Proposed replicative role of the NS polypeptide of vesicular stomatitis virus: structural analysis of an electrophoretic variant.

Authors:  J A Lesnaw; L R Dickson; R H Curry
Journal:  J Virol       Date:  1979-07       Impact factor: 5.103

2.  Temperature-sensitive mutants of complementation group E of vesicular stomatitis virus New Jersey serotype possess altered NS polypeptides.

Authors:  D Evans; C R Pringle; J F Szilágyi
Journal:  J Virol       Date:  1979-08       Impact factor: 5.103

3.  Specific protein phosphorylation in interferon-treated uninfected and virus-infected mouse L929 cells: enhancement by double-stranded RNA.

Authors:  S L Gupta
Journal:  J Virol       Date:  1979-01       Impact factor: 5.103

4.  The phosphoprotein of rabies virus is phosphorylated by a unique cellular protein kinase and specific isomers of protein kinase C.

Authors:  A K Gupta; D Blondel; S Choudhary; A K Banerjee
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

5.  Both NS and L proteins are required for in vitro RNA synthesis by vesicular stomatitis virus.

Authors:  S U Emerson; Y Yu
Journal:  J Virol       Date:  1975-06       Impact factor: 5.103

6.  Structure-function relationships and mode of replication of animal rhabdoviruses.

Authors:  F Sokol; H Koprowski
Journal:  Proc Natl Acad Sci U S A       Date:  1975-03       Impact factor: 11.205

7.  Translation of individual species of vesicular stomatitis viral mRNA.

Authors:  D Knipe; J K Rose; H F Lodish
Journal:  J Virol       Date:  1975-04       Impact factor: 5.103

8.  Translation and identification of the mRNA species synthesized in vitro by the virion-associated RNA polymerase of vesicular stomatitis virus.

Authors:  G W Both; S A Moyer; A K Banerjee
Journal:  Proc Natl Acad Sci U S A       Date:  1975-01       Impact factor: 11.205

9.  Translation and identification of the viral mRNA species isolated from subcellular fractions of vesicular stomatitis virus-infected cells.

Authors:  G W Both; S A Moyer; A K Banerjee
Journal:  J Virol       Date:  1975-04       Impact factor: 5.103

10.  In vitro phosphorylation and purification of a nonstructural protein of bluetongue virus with affinity for single-stranded RNA.

Authors:  H Huismans; A A van Dijk; A R Bauskin
Journal:  J Virol       Date:  1987-11       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.